Class II recall: American Regent, Inc.: Atropine Sulfate injection, USP, 1 mg/mL, For intravenous Use, Sterile, packaged

American Regent, Inc. issued a Class II recall of Atropine Sulfate Injection, USP, 1 mg/mL for intravenous use, packaged in 1 mL and 25x1 mL single-dose vials (NDC 0517-1001-01 and 0517-1001-25). The recall notice states the product was found to be contaminated with particulate matter identified as hair, glass, and/or paraformaldehyde. The affected lots were manufactured by American Regent Inc., Shirley, NY.

Most relevant for: Patients who may have received atropine sulfate injection from the recalled lots or healthcare facilities using the affected product batches for emergency treatment, anesthesia, or other clinical indications requiring intravenous atropine administration.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.